Yunong Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunong Shen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Chunhao Yu
School of Life Science, Beijing Institute of Technology, Beijing, 100081, China
1 shared publicationDafu Chen
Laboratory of Bone Tissue Engineering, Beijing Laboratory of Biomedical Materials, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Beijing, 100035, China
1 shared publication- Dandan Xia
Department of Dental Materials, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Key Laboratory of Digital Stomatology & NMPA Key Laboratory for Dental Materials, Beijing, China
1 shared publication - Duo Chen
Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
1 shared publication Hongkang Zhang
School of Materials Science and Engineering, Peking University, Beijing, 100083, China
1 shared publication- Kun Wang
School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 54, 730-743
Hydrodynamic-derived centrifugal blood pump design for stable-low-flow-rate rate performance: from surface to structure
Long-lasting stability of the anticoagulant coating on centrifugal blood pumps (CBPs) is of vital importance to ensure the hemocompatibility of the blood circulation system therein. Heparin coatings are often prepared using static wet chemical technique, but these face risks of delamination or deactivation induced by blood flow. Inspired by the flow-shear-stress mediated conformation changes of von Willebrand factor, a novel fluid-driven deposition technique was employed to apply polydopamine-heparin coatings within CBPs. Moreover, most FDA-approved CBPs are designed for high-flow-rate CBPs of major organs like the heart and lungs (1000∼8000 ml/min). Few are tailored for low-flow-rate perfusion of other organs such as the liver, kidney and brain (<50–300 mL/min). Our approach addresses this gap by developing low-flow-rate CBPs through anti-thrombogenic coatings and anti-hemolytic structural optimizations. In this study, we introduced an axial magnetic direct drive motor with our optimized low-flow-rate CBPs, achieving a stable-low-flow-rate rate ranging from 16.3 mL/min (300 rpm) to 121.0 mL/min (2000 rpm). The resulting CBPs system exhibited enhanced flow stability and hemocompatibility in rabbit model experiments, demonstrating significantly lower hemolysis rates and lower thrombus formation risks. These results indicate that the polydopamine-assisted heparin coating provides short-term stability under dynamic flow, offering a promising strategy for low-flow-rate CBPs, though its long-term durability and clinical translation potential require further validation.
- 1 December 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 54, 730-743
Open AccessHydrodynamic-derived centrifugal blood pump design for stable-low-flow-rate rate performance: from surface to structure
Long-lasting stability of the anticoagulant coating on centrifugal blood pumps (CBPs) is of vital importance to ensure the hemocompatibility of the blood circulation system therein. Heparin coatings are often prepared using static wet chemical technique, but these face risks of delamination or deactivation induced by blood flow. Inspired by the flow-shear-stress mediated conformation changes of von Willebrand factor, a novel fluid-driven deposition technique was employed to apply polydopamine-heparin coatings within CBPs. Moreover, most FDA-approved CBPs are designed for high-flow-rate CBPs of major organs like the heart and lungs (1000∼8000 ml/min). Few are tailored for low-flow-rate perfusion of other organs such as the liver, kidney and brain (<50–300 mL/min). Our approach addresses this gap by developing low-flow-rate CBPs through anti-thrombogenic coatings and anti-hemolytic structural optimizations. In this study, we introduced an axial magnetic direct drive motor with our optimized low-flow-rate CBPs, achieving a stable-low-flow-rate rate ranging from 16.3 mL/min (300 rpm) to 121.0 mL/min (2000 rpm). The resulting CBPs system exhibited enhanced flow stability and hemocompatibility in rabbit model experiments, demonstrating significantly lower hemolysis rates and lower thrombus formation risks. These results indicate that the polydopamine-assisted heparin coating provides short-term stability under dynamic flow, offering a promising strategy for low-flow-rate CBPs, though its long-term durability and clinical translation potential require further validation.
- Open Access
- 1 June 2023
- Published by KEAI Publishing in Bioactive Materials
- Vol. 24, 507-523
Systematic in vitro and in vivo study on biodegradable binary Zn-0.2 at% Rare Earth alloys (Zn-RE: Sc, Y, La–Nd, Sm–Lu)
Biomedical implants and devices for tissue engineering in clinics, mainly made of polymers and stiff metallic materials, require possibly secondary surgery or life-long medicine. Biodegradable metals for biomedical implants and devices exhibit huge potential to improve the prognosis of patients. In this work, we developed a new type of biodegradable binary zinc (Zn) alloys with 16 rare earth elements (REEs) including Sc, Y, La to Nd, and Sm to Lu, respectively. The effects of REEs on the alloy microstructure, mechanical properties, corrosion behavior and in vitro and in vivo biocompatibility of Zn were systematically investigated using pure Zn as control. All Zn-RE alloys generally exhibited improved mechanical properties, and biocompatibilities compared to pure Zn, especially the tensile strength and ductility of Zn-RE alloys were dramatically enhanced. Among the Zn-RE alloys, different REEs presented enhancement effects at varied extent. Y, Ho and Lu were the three elements displaying greatest improvements in majority of alloys properties, while Eu, Gd and Dy exhibited least improvement. Furthermore, the Zn-RE alloys were comparable with other Zn alloys and also exhibited superior properties to Mg-RE alloys. The in vivo experiment using Zn-La, Zn-Ce, and Zn-Nd alloys as tibia bone implants in rabbit demonstrated the excellent tissue biocompatibility and much more obvious osseointegration than the pure Zn control group. This work presented the significant potential of the developed Zn-RE binary alloys as novel degradable metal for biomedical implants and devices.
- 1 June 2023
- Published by KEAI Publishing in Bioactive Materials
- Vol. 24, 507-523
Open AccessSystematic in vitro and in vivo study on biodegradable binary Zn-0.2 at% Rare Earth alloys (Zn-RE: Sc, Y, La–Nd, Sm–Lu)
Biomedical implants and devices for tissue engineering in clinics, mainly made of polymers and stiff metallic materials, require possibly secondary surgery or life-long medicine. Biodegradable metals for biomedical implants and devices exhibit huge potential to improve the prognosis of patients. In this work, we developed a new type of biodegradable binary zinc (Zn) alloys with 16 rare earth elements (REEs) including Sc, Y, La to Nd, and Sm to Lu, respectively. The effects of REEs on the alloy microstructure, mechanical properties, corrosion behavior and in vitro and in vivo biocompatibility of Zn were systematically investigated using pure Zn as control. All Zn-RE alloys generally exhibited improved mechanical properties, and biocompatibilities compared to pure Zn, especially the tensile strength and ductility of Zn-RE alloys were dramatically enhanced. Among the Zn-RE alloys, different REEs presented enhancement effects at varied extent. Y, Ho and Lu were the three elements displaying greatest improvements in majority of alloys properties, while Eu, Gd and Dy exhibited least improvement. Furthermore, the Zn-RE alloys were comparable with other Zn alloys and also exhibited superior properties to Mg-RE alloys. The in vivo experiment using Zn-La, Zn-Ce, and Zn-Nd alloys as tibia bone implants in rabbit demonstrated the excellent tissue biocompatibility and much more obvious osseointegration than the pure Zn control group. This work presented the significant potential of the developed Zn-RE binary alloys as novel degradable metal for biomedical implants and devices.